Sign in

NOVARTIS AG

Income Statement - NOVARTIS AG (NVS)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14 Dec-13 Dec-12 Dec-11 Dec-10 Dec-09 Dec-08 Dec-07 Dec-06
Total revenue 54.81 51.72 46.66 43.46 43.97 49.90 48.68 46.10 43.40 49.44 50.39 53.63 52.72 51.97 59.38 51.56 45.10 42.58 38.95 35.11
Cost of revenue 13.69 12.83 12.47 11.58 11.74 15.12 14.43 14.51 13.63 17.52 17.40 17.35 16.58 15.87 18.98 14.49 12.18 11.44 11.03 9.41
Gross profit 41.12 38.90 34.19 31.88 32.24 34.78 34.25 31.59 29.77 31.92 32.98 36.29 36.14 36.11 40.39 37.07 32.92 31.15 27.92 25.69
Total operating expenses + 24.05 24.35 24.42 23.93 22.18 24.63 25.17 23.19 21.07 23.65 24.01 25.20 25.15 24.60 29.61 25.55 22.94 22.18 21.13 18.05
Operating income 17.07 14.54 9.77 7.95 10.06 10.15 9.09 8.40 8.70 8.27 8.98 11.09 10.98 11.51 10.78 11.53 9.98 8.96 6.78 7.64
Non-operating income (net) -0.64 -0.90 -0.65 -0.77 14.47 -0.27 -0.15 5.69 0.40 -0.45 -0.84 1.18 -0.18 -0.27 -0.23 0.18 -0.06 0.54 0.71 0.35
Income before tax 16.44 13.64 9.12 7.18 24.53 9.88 8.94 14.10 9.10 7.82 8.13 12.27 10.81 11.24 10.56 11.70 9.92 9.50 7.49 7.99
Income tax expense 2.40 1.70 0.55 1.13 1.63 1.81 1.79 1.30 1.60 1.12 1.11 1.55 1.50 1.71 1.48 1.73 1.47 1.34 0.95 1.17
Net income 14.06 11.94 14.85 6.96 24.02 8.07 11.73 12.61 7.70 6.71 17.78 10.21 9.18 9.27 8.94 9.79 8.40 8.20 11.95 7.18
Show Quarterly Income Statement

Income Statement - NOVARTIS AG (NVS)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18 Dec-17 Sep-17 Jun-17 Mar-17 Dec-16 Sep-16 Jun-16 Mar-16 Dec-15 Sep-15 Jun-15 Mar-15 Dec-14 Sep-14 Jun-14 Mar-14 Dec-13 Sep-13 Jun-13 Mar-13 Dec-12 Sep-12 Jun-12 Mar-12 Dec-11 Sep-11 Jun-11 Mar-11 Dec-10 Sep-10 Jun-10 Mar-10 Dec-09 Sep-09 Jun-09 Mar-09 Dec-08 Sep-08 Jun-08 Mar-08 Dec-07 Sep-07 Jun-07 Mar-07 Dec-06 Sep-06 Jun-06 Mar-06
Total revenue 13.52 13.33 14.36 14.84 13.62 13.56 13.17 12.87 12.12 11.78 12.09 11.75 11.05 13.09 10.78 13.09 12.81 13.52 13.37 13.29 12.69 13.03 12.54 11.62 12.71 12.72 12.48 12.02 11.46 13.66 11.39 11.65 11.16 13.16 12.69 12.49 11.79 12.61 12.34 12.68 11.81 12.80 12.49 12.90 12.20 13.35 13.30 13.95 13.03 15.36 12.91 13.28 14.21 15.07 14.04 14.54 13.91 15.00 15.03 15.12 14.22 14.46 12.82 11.92 12.36 13.15 11.29 10.74 9.93 10.35 11.03 10.99 10.22 10.17 9.82 9.40 9.37 9.32 9.02 8.51 8.15
Cost of revenue 3.46 3.54 3.54 3.32 3.23 3.32 3.23 3.17 3.10 3.02 3.12 3.34 2.99 4.07 2.87 3.75 3.86 3.98 3.94 3.91 4.04 4.22 3.75 3.43 3.72 3.99 3.78 3.41 3.25 4.93 3.46 3.56 3.45 4.49 4.32 4.26 4.11 4.49 4.37 4.45 4.21 4.55 4.39 4.49 3.98 4.42 4.42 4.38 4.13 5.31 4.13 4.09 4.61 5.09 4.58 4.61 4.48 5.12 4.79 4.62 4.46 4.52 3.66 3.21 3.10 3.67 3.10 2.82 2.81 2.83 3.02 2.94 2.65 3.01 3.03 2.50 2.49 2.51 2.53 2.23 2.18
Gross profit 10.07 9.79 10.82 11.51 10.39 10.23 9.94 9.70 9.02 8.75 8.98 8.40 8.06 9.01 7.91 9.33 8.96 9.55 9.43 9.38 8.66 8.81 8.79 8.19 8.99 8.72 8.71 8.62 8.20 8.74 7.92 8.10 7.71 8.68 8.37 8.24 7.68 8.12 7.97 8.23 7.60 8.26 8.10 8.41 8.22 8.94 8.88 9.57 8.90 10.05 8.78 9.19 9.60 9.98 9.46 9.93 9.43 9.88 10.25 10.50 9.76 9.94 9.16 8.72 9.26 9.48 8.19 7.92 7.12 7.51 8.01 8.05 7.57 7.16 6.78 6.90 6.89 6.81 6.50 6.28 5.97
Total operating expenses + 5.83 6.27 6.32 6.65 5.73 6.70 6.31 5.69 5.65 6.17 7.21 5.60 5.44 7.07 6.08 7.11 6.11 6.98 6.20 5.90 6.24 6.17 6.37 5.84 6.24 6.90 6.35 5.96 5.96 7.44 5.68 5.66 5.34 6.61 6.01 5.96 5.76 6.66 5.70 6.14 5.15 6.58 5.86 6.13 5.44 6.59 6.14 6.39 6.09 7.68 6.22 6.16 6.70 7.50 6.52 6.82 6.69 8.56 7.30 7.18 6.36 7.47 6.57 5.75 5.75 6.84 5.55 5.55 4.77 5.83 5.67 5.59 5.08 6.85 4.74 4.67 4.55 5.21 4.52 4.06 3.91
Operating income 4.24 3.52 4.50 4.86 4.66 3.53 3.63 4.01 3.37 2.58 1.76 2.81 2.62 1.95 1.83 2.23 2.85 2.56 3.23 3.48 2.42 2.64 2.41 2.35 2.74 1.82 2.36 2.66 2.24 1.30 2.24 2.43 2.37 2.07 2.36 2.28 1.92 1.46 2.27 2.09 2.45 1.68 2.23 2.28 2.79 2.35 2.74 3.18 2.82 2.37 2.56 3.03 2.90 2.48 2.95 3.11 2.74 1.32 2.95 3.32 3.41 2.47 2.59 2.96 3.51 2.64 2.63 2.36 2.35 1.68 2.34 2.46 2.49 0.31 2.04 2.23 2.34 1.60 1.98 2.23 2.06
Non-operating income (net) -0.40 -0.30 -0.31 -0.33 -0.26 -0.25 -0.24 -0.17 -0.24 -0.21 -0.21 -0.13 -0.10 -0.21 -0.24 -0.19 -0.18 14.39 0.00 0.03 0.04 -0.09 0.00 -0.06 -0.12 -0.06 0.05 -0.03 -0.10 -0.04 0.01 5.74 -0.03 0.23 0.08 0.04 0.03 -0.38 0.01 0.02 -0.10 -0.55 -0.07 -0.13 -0.11 0.41 0.79 -0.04 0.02 -0.05 -0.07 0.00 -0.06 -0.05 -0.17 0.03 -0.08 -0.06 -0.04 -0.08 -0.05 -0.05 0.21 0.00 0.02 0.06 -0.14 0.08 -0.05 0.08 0.09 0.14 0.23 0.88 -0.47 0.00 0.13 0.11 0.08 -0.26 0.15
Income before tax 3.84 3.22 4.20 4.53 4.41 3.29 3.39 3.84 3.13 2.38 1.55 2.67 2.52 1.74 1.59 2.04 2.67 16.95 3.23 3.51 2.45 2.56 2.41 2.29 2.62 1.76 2.41 2.63 2.14 1.26 2.25 8.17 2.34 2.30 2.44 2.32 1.95 1.08 2.27 2.11 2.35 1.13 2.17 2.16 2.68 2.76 3.53 3.15 2.84 2.32 2.49 3.03 2.84 2.43 2.78 3.14 2.66 1.26 2.91 3.25 3.36 2.42 2.79 2.96 3.53 2.69 2.49 2.44 2.30 1.76 2.42 2.60 2.72 1.19 1.57 2.23 2.47 1.71 2.06 1.97 2.21
Income tax expense 0.68 0.81 0.27 0.51 0.80 0.47 0.20 0.60 0.44 -0.26 0.04 0.40 0.37 0.28 0.26 0.35 0.45 0.65 0.47 0.61 0.39 0.46 0.48 0.42 0.45 0.63 0.37 0.53 0.27 0.07 0.37 0.44 0.37 0.33 0.35 0.34 0.28 0.14 0.33 0.31 0.34 0.08 0.36 0.30 0.37 0.31 0.43 0.42 0.38 0.26 0.33 0.45 0.42 0.35 0.36 0.46 0.39 0.05 0.42 0.52 0.54 0.16 0.48 0.52 0.58 0.37 0.38 0.40 0.32 0.25 0.34 0.34 0.41 0.25 0.04 0.28 0.37 0.23 0.27 0.32 0.37
Net income 3.16 2.41 3.93 4.04 3.61 2.82 3.19 3.25 2.69 8.48 1.76 2.32 2.29 1.47 1.57 1.69 2.22 16.31 2.76 2.90 2.06 2.09 1.94 1.87 2.18 1.13 2.04 6.80 1.77 1.20 1.62 7.77 2.03 1.98 2.08 1.98 1.67 0.96 1.94 1.80 2.01 1.05 1.89 1.84 13.01 1.49 3.22 2.56 2.94 2.03 2.23 2.52 2.40 2.05 2.39 2.65 2.25 1.18 2.46 2.70 2.77 2.17 2.28 2.42 2.93 2.31 2.10 2.04 1.96 1.54 2.09 2.25 2.32 0.90 6.87 2.01 2.17 1.65 1.87 1.71 1.95
about 2 months ago

Balance Sheet - NOVARTIS AG (NVS)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14 Dec-13 Dec-12 Dec-11 Dec-10 Dec-09 Dec-08 Dec-07 Dec-06
Total cash and short-term investments + 11.59 13.35 13.96 18.62 28.11 11.56 11.45 15.96 9.49 7.78 5.45 13.86 9.22 8.12 5.08 8.13 17.45 6.12 13.20 7.96
Accounts receivable, net 10.93 8.21 9.38 9.89 9.62 9.07 9.17 9.68 10.07 10.20 10.55 10.26 12.62 12.53 12.37 11.72 10.01 8.57 8.50 7.97
Inventories 6.27 5.72 5.91 7.18 6.67 7.13 5.98 6.96 6.87 6.26 6.23 6.09 7.27 6.74 5.93 6.09 5.83 5.79 5.46 4.50
Other current assets 1.67 2.42 1.23 1.23 1.32 1.91 2.90 4.05 1.79 0.70 0.62 7.35 1.43 0.61 0.71 0.74 0.40 0.40 0.27 0.98
Total current assets 30.46 29.70 30.48 36.91 45.72 29.67 29.50 35.56 28.21 24.93 22.85 37.56 30.54 28.00 24.08 26.69 33.69 20.88 27.43 21.40
Total non-current assets + 85.11 72.54 69.46 80.54 86.08 102.52 88.91 110.00 104.87 105.19 108.71 87.83 95.71 96.21 93.41 96.63 61.81 57.42 48.02 46.60
Total assets 115.57 102.25 99.95 117.45 131.80 132.19 118.41 145.56 133.08 130.12 131.56 125.39 126.25 124.22 117.50 123.32 95.51 78.30 75.45 68.01
Total current liabilities + 27.28 28.69 26.39 28.66 30.21 33.06 28.26 29.61 23.40 22.21 23.71 26.97 26.37 24.05 23.15 24.66 19.47 16.50 16.64 16.23
Total non-current liabilities + 41.74 29.43 26.81 29.37 33.77 42.46 34.60 37.26 35.45 33.02 30.73 27.57 25.41 30.95 28.41 28.89 18.57 11.36 9.42 10.48
Total liabilities 69.02 58.12 53.20 58.03 63.97 75.52 62.86 66.87 58.85 55.23 54.43 54.54 51.78 55.00 51.56 53.55 38.04 27.86 26.06 26.71
Total stockholders' equity + 46.13 44.05 46.67 59.34 67.66 56.60 55.47 78.61 74.17 74.83 77.05 70.77 74.34 69.09 65.84 63.20 57.39 50.29 49.22 41.11
Common shares outstanding 1,955 2,035 2,092 2,197 2,260 2,296 2,319 2,344 2,371 2,400 2,438 2,470 2,479 2,445 2,413 2,301 2,277 2,284 2,329 2,360
Show Quarterly Balance Sheet

Balance Sheet - NOVARTIS AG (NVS)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18 Dec-17 Sep-17 Jun-17 Mar-17 Dec-16 Sep-16 Jun-16 Mar-16 Dec-15 Sep-15 Jun-15 Mar-15 Dec-14 Sep-14 Jun-14 Mar-14 Dec-13 Sep-13 Jun-13 Mar-13 Dec-12 Sep-12 Jun-12 Mar-12 Dec-11 Sep-11 Jun-11 Mar-11 Dec-10 Sep-10 Jun-10 Mar-10 Dec-09 Sep-09 Jun-09 Mar-09 Dec-08 Sep-08 Jun-08 Mar-08 Dec-07 Sep-07 Jun-07 Mar-07 Dec-06 Sep-06 Jun-06 Mar-06
Total cash and short-term investments + 6.98 11.59 9.75 7.00 7.20 13.35 14.02 8.44 9.69 14.43 12.70 11.17 12.26 18.93 19.10 19.76 18.81 28.33 8.16 5.36 4.08 11.56 10.87 6.29 4.97 11.45 8.72 10.34 7.11 15.96 14.71 13.15 6.42 9.49 9.40 8.42 8.24 7.78 7.74 5.65 5.07 5.45 5.93 5.81 8.25 13.86 10.43 7.32 7.72 9.22 7.27 5.09 6.04 8.12 5.80 6.11 5.39 5.08 5.57 5.60 8.76 8.13 7.99 23.00 19.90 17.45 14.17 11.82 7.84 6.12 8.14 16.20 10.85 13.20 14.53 7.55 6.96 7.96 8.53 7.31 11.12
Accounts receivable, net 9.60 10.93 8.98 9.18 8.73 8.21 8.15 8.48 8.25 8.12 7.10 9.54 9.18 8.94 8.68 8.91 8.68 8.83 8.63 8.65 8.48 9.07 8.30 7.95 8.80 9.17 8.07 8.25 7.85 9.68 8.77 8.99 9.12 10.07 8.48 8.38 8.23 10.20 8.55 8.61 8.46 8.18 8.50 8.75 8.79 10.26 8.86 9.37 10.32 9.90 10.50 10.79 10.48 11.11 10.52 10.49 10.61 12.37 10.70 10.92 10.86 11.72 10.39 7.80 7.77 10.01 7.82 7.17 6.75 8.57 7.25 7.14 6.88 8.50 6.81 6.23 6.35 7.97 6.09 5.89 5.29
Inventories 6.29 6.27 6.42 6.31 5.83 5.72 5.94 5.75 5.74 5.91 5.61 8.23 7.89 7.18 6.78 6.88 7.00 6.67 6.89 7.11 7.00 7.13 7.14 6.90 6.40 5.98 6.12 6.09 5.73 6.96 6.95 7.10 7.23 6.87 6.95 6.90 6.58 6.26 6.77 6.67 6.63 6.23 6.56 6.61 6.27 6.09 6.51 6.88 7.86 7.27 7.52 7.26 7.02 6.74 6.85 6.42 6.46 5.93 6.61 7.10 6.62 6.09 6.76 5.54 5.66 5.83 6.31 6.13 5.76 5.79 5.96 6.45 6.24 5.46 5.27 5.02 4.98 4.50 4.61 4.69 3.93
Other current assets 3.74 1.72 3.04 3.46 3.36 2.42 3.16 3.03 2.76 2.02 20.26 4.55 2.79 1.87 2.39 2.59 2.75 1.90 2.57 2.69 2.64 1.91 2.67 2.73 2.93 2.90 3.77 3.64 31.76 4.05 3.69 2.83 10.29 1.79 2.61 2.82 2.71 0.70 2.78 2.79 2.83 2.99 3.06 3.57 3.28 9.69 10.99 11.41 3.78 3.39 3.48 3.70 3.26 3.09 8.78 9.22 8.72 0.71 8.26 8.62 11.62 0.74 10.57 25.33 22.37 0.40 16.32 13.88 9.97 0.40 1.95 2.30 2.31 0.27 2.07 1.83 3.04 0.98 1.75 1.91 1.58
Total current assets 26.61 30.46 28.20 25.94 25.11 29.70 31.26 25.69 26.45 30.48 45.66 33.49 32.11 36.91 36.95 38.14 37.24 45.72 26.25 23.81 22.20 29.67 28.97 23.88 23.10 29.50 26.68 28.32 52.45 35.56 34.11 32.07 33.05 28.21 27.47 26.54 25.77 24.93 25.88 23.72 22.99 22.85 24.05 24.75 25.71 37.56 36.79 34.97 29.69 30.54 28.77 26.85 26.80 28.00 26.15 26.12 25.79 24.08 25.56 26.63 29.10 26.69 27.72 38.67 35.80 33.69 30.44 27.17 22.48 20.88 23.30 32.09 26.29 27.43 28.68 20.64 21.33 21.40 20.97 19.80 21.92
Total non-current assets + 91.93 85.11 79.09 78.46 74.83 72.54 72.26 71.81 67.89 73.34 67.04 77.49 80.13 84.86 81.51 84.77 87.98 90.17 94.96 100.21 99.55 102.52 100.71 99.88 100.00 88.91 89.30 87.97 85.50 110.00 108.88 109.99 102.47 104.87 107.51 107.21 106.22 105.19 108.12 107.71 109.46 108.71 108.88 110.67 109.23 87.83 88.59 90.80 95.64 95.71 95.82 94.23 94.22 96.21 95.07 92.37 93.62 93.41 95.81 99.29 98.12 96.63 96.91 58.26 60.00 61.81 60.25 57.10 55.49 57.42 58.72 51.31 50.03 48.02 48.25 49.98 46.99 46.60 45.89 46.13 36.93
Total assets 118.53 115.57 107.29 104.40 99.94 102.25 103.52 97.51 94.33 103.82 112.70 110.98 112.24 121.77 118.46 122.91 125.22 135.88 121.21 124.02 121.75 132.19 129.68 123.76 123.10 118.41 115.97 116.29 137.95 145.56 142.99 142.06 135.52 133.08 134.97 133.75 131.99 130.12 134.01 131.44 132.45 131.56 132.93 135.41 134.94 125.39 125.38 125.77 125.33 126.25 124.59 121.07 121.01 124.22 121.22 118.49 119.41 117.50 121.38 125.92 127.22 123.32 124.63 96.92 95.80 95.51 90.69 84.27 77.97 78.30 82.02 83.40 76.32 75.45 76.94 70.62 68.32 68.01 66.86 65.93 58.85
Total current liabilities + 31.37 27.28 32.00 31.71 31.62 28.69 28.13 27.61 29.29 26.39 48.39 31.91 30.55 28.66 28.16 27.65 29.81 30.21 29.88 29.63 30.16 33.06 31.84 29.38 31.29 28.26 28.22 30.11 56.13 29.61 28.33 27.94 28.22 23.40 25.38 26.15 26.33 22.21 24.60 26.27 27.82 23.71 28.16 29.39 29.05 26.97 26.62 27.56 24.76 26.37 25.81 24.39 26.37 24.05 21.86 24.92 27.36 23.15 25.83 29.54 32.22 24.66 27.66 17.83 17.43 19.47 17.90 15.36 14.99 16.50 19.95 19.68 17.06 16.64 17.50 15.98 17.55 16.23 16.32 16.76 15.59
Total non-current liabilities + 48.23 41.74 30.54 30.63 29.87 29.43 31.95 27.99 25.29 30.68 26.06 27.14 29.55 33.69 29.41 32.26 33.71 37.85 34.39 40.25 41.00 42.46 43.29 40.50 40.83 34.60 35.15 34.68 34.51 37.26 36.65 37.21 36.09 35.45 37.22 37.63 38.01 33.02 34.34 32.63 32.74 30.73 27.98 27.19 29.44 27.57 27.34 27.70 30.24 25.41 26.60 27.06 27.49 30.95 32.16 29.33 28.85 28.41 29.41 29.29 29.66 28.89 30.75 23.28 23.15 18.57 19.47 18.43 16.75 11.36 11.33 12.11 10.00 9.42 9.94 10.98 10.27 10.48 11.96 12.01 9.50
Total liabilities 79.61 69.02 62.54 62.34 61.49 58.12 60.08 55.60 54.58 57.07 74.45 59.05 60.10 62.34 57.57 59.90 63.51 68.06 64.27 69.89 71.16 75.52 75.12 69.88 72.12 62.86 63.37 64.79 90.64 66.87 64.98 65.16 64.31 58.85 62.60 63.77 64.34 55.23 58.94 58.90 60.56 54.43 56.14 56.58 58.49 54.54 53.95 55.25 55.00 51.78 52.42 51.44 53.86 55.00 54.01 54.25 56.21 51.56 55.24 58.82 61.88 53.55 58.41 41.11 40.58 38.04 37.37 33.79 31.74 27.86 31.28 31.79 27.05 26.06 27.44 26.96 27.82 26.71 28.27 28.77 25.09
Total stockholders' equity + 38.51 46.13 44.33 41.99 38.37 44.05 43.32 41.73 39.68 46.67 38.16 51.85 52.06 59.34 60.82 62.93 61.54 67.66 56.77 54.04 50.52 56.60 54.48 53.81 50.90 55.47 52.52 51.43 47.23 78.61 77.94 76.82 71.10 74.17 72.31 69.92 67.59 74.83 74.98 72.46 71.81 77.05 76.71 78.76 76.38 70.77 71.34 70.39 70.21 74.34 72.05 69.49 67.03 69.09 67.08 64.13 63.11 65.84 66.14 67.09 65.34 63.20 66.22 55.82 55.22 57.39 53.31 50.49 46.23 50.29 50.74 51.61 49.27 49.22 49.49 43.66 40.50 41.11 38.59 37.16 33.75
Common shares outstanding 1,916 1,929 1,940 1,960 1,979 2,004 2,027 2,046 2,056 2,065 2,075 2,095 2,120 2,150 2,180 2,211 2,237 2,253 2,254 2,258 2,265 2,282 2,302 2,304 2,292 2,292 2,297 2,333 2,339 2,336 2,338 2,346 2,347 2,348 2,359 2,373 2,389 2,395 2,401 2,401 2,398 2,418 2,438 2,451 2,446 2,449 2,460 2,471 2,479 2,469 2,480 2,490 2,473 2,451 2,445 2,441 2,435 2,424 2,450 2,426 2,305 2,288 2,300 2,297 2,290 2,268 2,285 2,280 2,283 2,264 2,283 2,286 2,273 2,312 2,322 2,352 2,359 2,348 2,362 2,362 2,355
about 2 months ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14 Dec-13 Dec-12 Dec-11 Dec-10 Dec-09 Dec-08 Dec-07 Dec-06
Operating cash flow + 19.24 17.62 14.46 14.24 15.07 13.65 13.63 14.27 12.62 11.48 11.90 13.90 13.17 14.19 14.31 14.07 12.19 9.77 9.21 8.71
Cash flow from investing + -4.90 -7.51 5.60 1.47 4.21 -13.18 -2.23 -5.59 -3.12 -3.44 -10.78 0.88 -3.35 -5.68 -0.79 -15.76 -14.22 -10.37 -6.24 -6.58
Cash flow from financing + -14.94 -11.74 -14.28 -20.56 -16.26 -2.21 -13.63 -4.24 -7.73 -5.31 -9.18 -8.15 -8.77 -6.68 -15.02 4.12 2.81 -2.57 -9.32 -4.97
Change in cash -0.60 -1.64 5.78 -4.86 3.02 -1.74 -2.23 4.44 1.77 2.72 -8.06 6.63 1.05 1.84 -1.51 2.43 0.78 -3.17 -6.35 -2.84
Show Quarterly Cash Flow
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18 Dec-17 Sep-17 Jun-17 Mar-17 Dec-16 Sep-16 Jun-16 Mar-16 Dec-15 Sep-15 Jun-15 Mar-15 Dec-14 Sep-14 Jun-14 Mar-14 Dec-13 Sep-13 Jun-13 Mar-13 Dec-12 Sep-12 Jun-12 Mar-12 Dec-11 Sep-11 Jun-11 Mar-11 Dec-10 Sep-10 Jun-10 Mar-10 Dec-09 Sep-09 Jun-09 Mar-09 Dec-08 Sep-08 Jun-08 Mar-08 Dec-07 Sep-07 Jun-07 Mar-07 Dec-06 Sep-06 Jun-06 Mar-06
Operating cash flow + 3.68 2.25 6.57 6.66 3.65 4.19 6.29 4.88 2.27 2.55 5.38 3.58 2.96 4.11 4.72 3.76 1.65 3.88 4.93 4.13 2.13 4.01 3.16 3.96 2.53 3.54 4.56 3.11 2.41 3.77 4.05 3.94 2.51 3.41 3.59 3.58 2.05 3.59 3.23 3.11 1.54 4.16 3.13 2.91 1.70 5.21 4.01 3.34 1.34 4.45 4.38 2.52 1.83 4.63 4.07 2.99 2.52 4.72 4.23 3.45 1.91 4.58 3.23 2.96 3.31 4.47 3.15 2.62 1.95 3.28 2.88 1.87 1.74 -5.02 10.19 1.81 2.22 2.29 2.52 1.76 2.14
Cash flow from investing + -11.74 -2.11 -0.86 -2.24 0.33 -3.03 -0.37 -3.21 -0.90 -1.11 -2.21 -1.05 10.62 -1.47 5.20 -11.63 9.37 4.56 -1.23 0.10 0.78 -0.57 -2.05 -0.43 -10.14 0.32 -3.40 -0.47 1.33 -4.94 -0.89 4.33 -4.10 -1.00 -0.69 -0.34 -1.10 -1.07 -0.75 -0.84 -0.77 -1.69 -0.75 -1.78 -6.56 -0.92 0.05 -1.08 2.82 -2.66 -0.75 -0.64 0.70 -2.54 -1.97 -0.72 -0.45 -0.82 -0.57 0.11 0.49 -0.59 -10.66 -3.37 -1.14 -4.19 -4.45 -2.73 -2.84 -1.73 -13.12 1.05 3.43 -1.68 -2.59 -0.73 -1.25 -0.83 -0.48 -5.02 -0.24
Cash flow from financing + 3.58 1.71 -2.79 -5.21 -8.55 -3.00 -0.38 -3.20 -5.16 -0.61 -0.83 -3.64 -9.20 -3.99 -4.74 -2.30 -9.53 -3.25 -1.53 -2.94 -8.54 -2.94 1.90 -2.19 1.01 -1.20 -2.71 -0.03 -9.68 0.45 -1.62 -1.53 -1.55 -2.40 -1.94 -3.01 -0.39 -2.30 -0.34 -1.64 -1.03 -2.78 -2.20 -2.45 -1.76 -0.74 -1.08 -2.64 -3.69 -1.52 -1.39 -2.52 -3.34 -1.14 -2.12 -1.67 -1.74 -4.22 -3.76 -6.56 -0.49 -4.06 7.20 0.95 0.02 -0.14 0.44 2.06 0.45 -3.75 0.69 4.18 -3.69 -3.16 -2.87 -0.81 -2.48 -1.94 -0.46 -0.82 -1.75
Change in cash -4.48 1.86 2.92 -0.79 -4.57 -1.84 5.53 -1.53 -3.80 0.83 2.33 -1.11 4.38 -1.35 5.18 -10.18 1.49 5.20 2.16 1.29 -5.63 0.50 3.01 1.35 -6.60 2.66 -1.55 2.61 -5.94 -0.72 1.54 6.74 -3.13 0.02 0.96 0.23 0.56 0.22 2.14 0.63 -0.26 -0.31 0.18 -1.32 -6.61 3.54 2.99 -0.38 0.48 0.28 2.23 -0.64 -0.82 0.95 -0.02 0.59 0.33 -0.32 -0.10 -3.00 1.91 -0.07 -0.23 0.54 2.19 0.13 -0.86 1.94 -0.44 -2.19 -9.56 7.10 1.49 -9.85 4.73 0.28 -1.51 -0.48 1.58 -4.08 0.16
about 2 months ago

NOVARTIS AG (NVS) - Shares Outstanding Diluted

1Y 2Y 5Y Max
about 2 months ago

NOVARTIS AG (NVS) - Net Income

1Y 2Y 5Y Max
about 2 months ago

NOVARTIS AG (NVS) - Stock Based Compensation

1Y 2Y 5Y Max
about 2 months ago

NOVARTIS AG (NVS) - Proceeds From Repurchase Of Equity

1Y 2Y 5Y Max
about 2 months ago

NOVARTIS AG (NVS) - Dividend Payout

1Y 2Y 5Y Max
about 2 months ago

NOVARTIS AG (NVS) - Cashflow From Financing

1Y 2Y 5Y Max
about 2 months ago

NOVARTIS AG (NVS) - Cashflow From Investment

1Y 2Y 5Y Max
about 2 months ago

NOVARTIS AG (NVS) - Change In Inventory

1Y 2Y 5Y Max
about 2 months ago

NOVARTIS AG (NVS) - Capital Expenditures

1Y 2Y 5Y Max
about 2 months ago

NOVARTIS AG (NVS) - Depreciation Depletion And Amortization

1Y 2Y 5Y Max
about 2 months ago